Volition
Marielle Herzog currently works at VolitionRx as the R&D Director for Belgian Volition. Marielle also serves as the Responsable de projet Nucleosomics, overseeing the development of NuQ® suite of products to address the need for cancer diagnostics. Before joining VolitionRx, Marielle worked as a Post-doctoral Researcher at the Laboratory of Cancer Epigenetics, where Marielle managed projects related to epigenetic modifications. Marielle holds a Ph.D. in Molecular and Cellular Biology from Université Louis Pasteur.
This person is not in any offices
Volition
1 followers
VolitionRx is developing a range of diagnostic tests for cancer and other conditions. Each test is based on the Nucleosomics® technology: measurement and…